Report cover image

Global Hemorrhoid Cream and Injector Market by Size, by Type, by Application, by Region, History and Forecast 2020-2031

Publisher APO Research, Inc.
Published Jul 08, 2025
Length 192 Pages
SKU # APRC20277858

Description

Summary

According to APO Research, The global Hemorrhoid Cream and Injector market is projected to grow from US$ million in 2025 to US$ million by 2031, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

The US & Canada market for Hemorrhoid Cream and Injector is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

Asia-Pacific market for Hemorrhoid Cream and Injector is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

The China market for Hemorrhoid Cream and Injector is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

Europe market for Hemorrhoid Cream and Injector is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

The major global manufacturers of Hemorrhoid Cream and Injector include Yunnan Baiyao Group, Xiuzheng Pharmaceutical Group, Takeda Pharmaceutical, Mayinglong Pharmaceutical Group, Tucks, Sun Pharma, Prestige Consumer Healthcare, Naticura and Medline Industries, etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.

This report presents an overview of global market for Hemorrhoid Cream and Injector, sales, revenue and price. Analyses of the global market trends, with historic market revenue or sales data for 2020-2024, estimates for 2025, and projections of CAGR through 2031.

This report researches the key producers of Hemorrhoid Cream and Injector, also provides the sales of main regions and countries. Of the upcoming market potential for Hemorrhoid Cream and Injector, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Hemorrhoid Cream and Injector sales, revenue, market share and industry ranking of main manufacturers, data from 2020 to 2025. Identification of the major stakeholders in the global Hemorrhoid Cream and Injector market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, sales, revenue, and price, from 2020 to 2031. Evaluation and forecast the market size for Hemorrhoid Cream and Injector sales, projected growth trends, production technology, application and end-user industry.

Hemorrhoid Cream and Injector Segment by Company

Yunnan Baiyao Group
Xiuzheng Pharmaceutical Group
Takeda Pharmaceutical
Mayinglong Pharmaceutical Group
Tucks
Sun Pharma
Prestige Consumer Healthcare
Naticura
Medline Industries
Ferndale Healthcare
eXroid
Doctor Bulter’s
Church and Dwight
Bausch Health
AdvaCare Pharma
Hemorrhoid Cream and Injector Segment by Type

Prescription Drug
Over-The-Counter Drug
Hemorrhoid Cream and Injector Segment by Application

Hospital
Household Use
Others
Hemorrhoid Cream and Injector Segment by Region

North America

United States
Canada
Mexico
Europe

Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific

China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America

Brazil
Argentina
Chile
Middle East & Africa

Egypt
South Africa
Israel
Türkiye
GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.
2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.
3. To split the breakdown data by regions, type, manufacturers, and Application.
4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify significant trends, drivers, influence factors in global and regions.
6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Hemorrhoid Cream and Injector market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Hemorrhoid Cream and Injector and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Hemorrhoid Cream and Injector.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Hemorrhoid Cream and Injector market, including product definition, global market growth prospects, market size, sales, and average price forecasts (2020-2031).
Chapter 2: Provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Hemorrhoid Cream and Injector manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Hemorrhoid Cream and Injector in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Revenue of Hemorrhoid Cream and Injector in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.
Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Concluding Insights of the report

Please Note: Single-User license will be delivered via PDF from the publisher without the rights to print or to edit.

Table of Contents

192 Pages
1 Market Overview
1.1 Product Definition
1.2 Global Hemorrhoid Cream and Injector Market Size, 2020 VS 2024 VS 2031
1.3 Global Hemorrhoid Cream and Injector Market Size Estimates and Forecasts (2020-2031)
1.4 Global Hemorrhoid Cream and Injector Sales Estimates and Forecasts (2020-2031)
1.5 Global Hemorrhoid Cream and Injector Market Average Price (2020-2031)
1.6 Assumptions and Limitations
1.7 Study Goals and Objectives
2 Global Hemorrhoid Cream and Injector Market Dynamics
2.1 Hemorrhoid Cream and Injector Industry Trends
2.2 Hemorrhoid Cream and Injector Industry Drivers
2.3 Hemorrhoid Cream and Injector Industry Opportunities and Challenges
2.4 Hemorrhoid Cream and Injector Industry Restraints
3 Hemorrhoid Cream and Injector Market by Manufacturers
3.1 Global Hemorrhoid Cream and Injector Revenue by Manufacturers (2020-2025)
3.2 Global Hemorrhoid Cream and Injector Sales by Manufacturers (2020-2025)
3.3 Global Hemorrhoid Cream and Injector Average Sales Price by Manufacturers (2020-2025)
3.4 Global Hemorrhoid Cream and Injector Industry Manufacturers Ranking, 2023 VS 2024 VS 2025
3.5 Global Hemorrhoid Cream and Injector Key Manufacturers Manufacturing Sites & Headquarters
3.6 Global Hemorrhoid Cream and Injector Manufacturers, Product Type & Application
3.7 Global Hemorrhoid Cream and Injector Manufacturers Establishment Date
3.8 Market Competitive Analysis
3.8.1 Global Hemorrhoid Cream and Injector Market CR5 and HHI
3.8.2 Global Top 5 and 10 Hemorrhoid Cream and Injector Players Market Share by Revenue in 2024
3.8.3 2024 Hemorrhoid Cream and Injector Tier 1, Tier 2, and Tier 3
4 Hemorrhoid Cream and Injector Market by Type
4.1 Hemorrhoid Cream and Injector Type Introduction
4.1.1 Prescription Drug
4.1.2 Over-The-Counter Drug
4.2 Global Hemorrhoid Cream and Injector Sales by Type
4.2.1 Global Hemorrhoid Cream and Injector Sales by Type (2020 VS 2024 VS 2031)
4.2.2 Global Hemorrhoid Cream and Injector Sales by Type (2020-2031)
4.2.3 Global Hemorrhoid Cream and Injector Sales Market Share by Type (2020-2031)
4.3 Global Hemorrhoid Cream and Injector Revenue by Type
4.3.1 Global Hemorrhoid Cream and Injector Revenue by Type (2020 VS 2024 VS 2031)
4.3.2 Global Hemorrhoid Cream and Injector Revenue by Type (2020-2031)
4.3.3 Global Hemorrhoid Cream and Injector Revenue Market Share by Type (2020-2031)
5 Hemorrhoid Cream and Injector Market by Application
5.1 Hemorrhoid Cream and Injector Application Introduction
5.1.1 Hospital
5.1.2 Household Use
5.1.3 Others
5.2 Global Hemorrhoid Cream and Injector Sales by Application
5.2.1 Global Hemorrhoid Cream and Injector Sales by Application (2020 VS 2024 VS 2031)
5.2.2 Global Hemorrhoid Cream and Injector Sales by Application (2020-2031)
5.2.3 Global Hemorrhoid Cream and Injector Sales Market Share by Application (2020-2031)
5.3 Global Hemorrhoid Cream and Injector Revenue by Application
5.3.1 Global Hemorrhoid Cream and Injector Revenue by Application (2020 VS 2024 VS 2031)
5.3.2 Global Hemorrhoid Cream and Injector Revenue by Application (2020-2031)
5.3.3 Global Hemorrhoid Cream and Injector Revenue Market Share by Application (2020-2031)
6 Global Hemorrhoid Cream and Injector Sales by Region
6.1 Global Hemorrhoid Cream and Injector Sales by Region: 2020 VS 2024 VS 2031
6.2 Global Hemorrhoid Cream and Injector Sales by Region (2020-2031)
6.2.1 Global Hemorrhoid Cream and Injector Sales by Region (2020-2025)
6.2.2 Global Hemorrhoid Cream and Injector Sales Forecasted by Region (2025-2030)
6.3 North America
6.3.1 North America Hemorrhoid Cream and Injector Sales Growth Rate by Country: 2020 VS 2024 VS 2031
6.3.2 North America Hemorrhoid Cream and Injector Sales by Country (2020-2031)
6.3.3 U.S.
6.3.4 Canada
6.3.5 Mexico
6.4 Europe
6.4.1 Europe Hemorrhoid Cream and Injector Sales Growth Rate by Country: 2020 VS 2024 VS 2031
6.4.2 Europe Hemorrhoid Cream and Injector Sales by Country (2020-2031)
6.4.3 Germany
6.4.4 France
6.4.5 U.K.
6.4.6 Italy
6.4.7 Netherlands
6.5 Asia Pacific
6.5.1 Asia Pacific Hemorrhoid Cream and Injector Sales Growth Rate by Country: 2020 VS 2024 VS 2031
6.5.2 Asia Pacific Hemorrhoid Cream and Injector Sales by Country (2020-2031)
6.5.3 China
6.5.4 Japan
6.5.5 South Korea
6.5.6 Southeast Asia
6.5.7 India
6.5.8 Australia
6.6 South America, Middle East and Africa
6.6.1 South America, Middle East and Africa Hemorrhoid Cream and Injector Sales Growth Rate by Country: 2020 VS 2024 VS 2031
6.6.2 South America, Middle East and Africa Hemorrhoid Cream and Injector Sales by Country (2020-2031)
6.6.3 Brazil
6.6.4 South Africa
6.6.5 Saudi Arabia
6.6.6 Turkey
6.6.6 Argentina
6.6.6 UAE
6.6.6 Egypt
6.6.6 Chile
7 Global Hemorrhoid Cream and Injector Revenue by Region
7.1 Global Hemorrhoid Cream and Injector Revenue by Region
7.1.1 Global Hemorrhoid Cream and Injector Revenue by Region: 2020 VS 2024 VS 2031
7.1.2 Global Hemorrhoid Cream and Injector Revenue by Region (2020-2025)
7.1.3 Global Hemorrhoid Cream and Injector Revenue by Region (2026-2031)
7.1.4 Global Hemorrhoid Cream and Injector Revenue Market Share by Region (2020-2031)
7.2 North America
7.2.1 North America Hemorrhoid Cream and Injector Revenue (2020-2031)
7.2.2 North America Hemorrhoid Cream and Injector Revenue Share by Country: 2020 VS 2024 VS 2031
7.3 Europe
7.3.1 Europe Hemorrhoid Cream and Injector Revenue (2020-2031)
7.3.2 Europe Hemorrhoid Cream and Injector Revenue Share by Country: 2020 VS 2024 VS 2031
7.4 Asia-Pacific
7.4.1 Asia-Pacific Hemorrhoid Cream and Injector Revenue (2020-2031)
7.4.2 Asia-Pacific Hemorrhoid Cream and Injector Revenue Share by Country: 2020 VS 2024 VS 2031
7.5 South America, Middle East and Africa
7.5.1 South America, Middle East and Africa Hemorrhoid Cream and Injector Revenue (2020-2031)
7.5.2 South America, Middle East and Africa Hemorrhoid Cream and Injector Revenue Share by Country: 2020 VS 2024 VS 2031
8 Company Profiles
8.1 Yunnan Baiyao Group
8.1.1 Yunnan Baiyao Group Comapny Information
8.1.2 Yunnan Baiyao Group Business Overview
8.1.3 Yunnan Baiyao Group Hemorrhoid Cream and Injector Sales, Price, Revenue and Gross Margin (2020-2025)
8.1.4 Yunnan Baiyao Group Hemorrhoid Cream and Injector Product Portfolio
8.1.5 Yunnan Baiyao Group Recent Developments
8.2 Xiuzheng Pharmaceutical Group
8.2.1 Xiuzheng Pharmaceutical Group Comapny Information
8.2.2 Xiuzheng Pharmaceutical Group Business Overview
8.2.3 Xiuzheng Pharmaceutical Group Hemorrhoid Cream and Injector Sales, Price, Revenue and Gross Margin (2020-2025)
8.2.4 Xiuzheng Pharmaceutical Group Hemorrhoid Cream and Injector Product Portfolio
8.2.5 Xiuzheng Pharmaceutical Group Recent Developments
8.3 Takeda Pharmaceutical
8.3.1 Takeda Pharmaceutical Comapny Information
8.3.2 Takeda Pharmaceutical Business Overview
8.3.3 Takeda Pharmaceutical Hemorrhoid Cream and Injector Sales, Price, Revenue and Gross Margin (2020-2025)
8.3.4 Takeda Pharmaceutical Hemorrhoid Cream and Injector Product Portfolio
8.3.5 Takeda Pharmaceutical Recent Developments
8.4 Mayinglong Pharmaceutical Group
8.4.1 Mayinglong Pharmaceutical Group Comapny Information
8.4.2 Mayinglong Pharmaceutical Group Business Overview
8.4.3 Mayinglong Pharmaceutical Group Hemorrhoid Cream and Injector Sales, Price, Revenue and Gross Margin (2020-2025)
8.4.4 Mayinglong Pharmaceutical Group Hemorrhoid Cream and Injector Product Portfolio
8.4.5 Mayinglong Pharmaceutical Group Recent Developments
8.5 Tucks
8.5.1 Tucks Comapny Information
8.5.2 Tucks Business Overview
8.5.3 Tucks Hemorrhoid Cream and Injector Sales, Price, Revenue and Gross Margin (2020-2025)
8.5.4 Tucks Hemorrhoid Cream and Injector Product Portfolio
8.5.5 Tucks Recent Developments
8.6 Sun Pharma
8.6.1 Sun Pharma Comapny Information
8.6.2 Sun Pharma Business Overview
8.6.3 Sun Pharma Hemorrhoid Cream and Injector Sales, Price, Revenue and Gross Margin (2020-2025)
8.6.4 Sun Pharma Hemorrhoid Cream and Injector Product Portfolio
8.6.5 Sun Pharma Recent Developments
8.7 Prestige Consumer Healthcare
8.7.1 Prestige Consumer Healthcare Comapny Information
8.7.2 Prestige Consumer Healthcare Business Overview
8.7.3 Prestige Consumer Healthcare Hemorrhoid Cream and Injector Sales, Price, Revenue and Gross Margin (2020-2025)
8.7.4 Prestige Consumer Healthcare Hemorrhoid Cream and Injector Product Portfolio
8.7.5 Prestige Consumer Healthcare Recent Developments
8.8 Naticura
8.8.1 Naticura Comapny Information
8.8.2 Naticura Business Overview
8.8.3 Naticura Hemorrhoid Cream and Injector Sales, Price, Revenue and Gross Margin (2020-2025)
8.8.4 Naticura Hemorrhoid Cream and Injector Product Portfolio
8.8.5 Naticura Recent Developments
8.9 Medline Industries
8.9.1 Medline Industries Comapny Information
8.9.2 Medline Industries Business Overview
8.9.3 Medline Industries Hemorrhoid Cream and Injector Sales, Price, Revenue and Gross Margin (2020-2025)
8.9.4 Medline Industries Hemorrhoid Cream and Injector Product Portfolio
8.9.5 Medline Industries Recent Developments
8.10 Ferndale Healthcare
8.10.1 Ferndale Healthcare Comapny Information
8.10.2 Ferndale Healthcare Business Overview
8.10.3 Ferndale Healthcare Hemorrhoid Cream and Injector Sales, Price, Revenue and Gross Margin (2020-2025)
8.10.4 Ferndale Healthcare Hemorrhoid Cream and Injector Product Portfolio
8.10.5 Ferndale Healthcare Recent Developments
8.11 eXroid
8.11.1 eXroid Comapny Information
8.11.2 eXroid Business Overview
8.11.3 eXroid Hemorrhoid Cream and Injector Sales, Price, Revenue and Gross Margin (2020-2025)
8.11.4 eXroid Hemorrhoid Cream and Injector Product Portfolio
8.11.5 eXroid Recent Developments
8.12 Doctor Bulter’s
8.12.1 Doctor Bulter’s Comapny Information
8.12.2 Doctor Bulter’s Business Overview
8.12.3 Doctor Bulter’s Hemorrhoid Cream and Injector Sales, Price, Revenue and Gross Margin (2020-2025)
8.12.4 Doctor Bulter’s Hemorrhoid Cream and Injector Product Portfolio
8.12.5 Doctor Bulter’s Recent Developments
8.13 Church and Dwight
8.13.1 Church and Dwight Comapny Information
8.13.2 Church and Dwight Business Overview
8.13.3 Church and Dwight Hemorrhoid Cream and Injector Sales, Price, Revenue and Gross Margin (2020-2025)
8.13.4 Church and Dwight Hemorrhoid Cream and Injector Product Portfolio
8.13.5 Church and Dwight Recent Developments
8.14 Bausch Health
8.14.1 Bausch Health Comapny Information
8.14.2 Bausch Health Business Overview
8.14.3 Bausch Health Hemorrhoid Cream and Injector Sales, Price, Revenue and Gross Margin (2020-2025)
8.14.4 Bausch Health Hemorrhoid Cream and Injector Product Portfolio
8.14.5 Bausch Health Recent Developments
8.15 AdvaCare Pharma
8.15.1 AdvaCare Pharma Comapny Information
8.15.2 AdvaCare Pharma Business Overview
8.15.3 AdvaCare Pharma Hemorrhoid Cream and Injector Sales, Price, Revenue and Gross Margin (2020-2025)
8.15.4 AdvaCare Pharma Hemorrhoid Cream and Injector Product Portfolio
8.15.5 AdvaCare Pharma Recent Developments
9 Value Chain and Sales Channels Analysis
9.1 Hemorrhoid Cream and Injector Value Chain Analysis
9.1.1 Hemorrhoid Cream and Injector Key Raw Materials
9.1.2 Raw Materials Key Suppliers
9.1.3 Manufacturing Cost Structure
9.1.4 Hemorrhoid Cream and Injector Production Mode & Process
9.2 Hemorrhoid Cream and Injector Sales Channels Analysis
9.2.1 Direct Comparison with Distribution Share
9.2.2 Hemorrhoid Cream and Injector Distributors
9.2.3 Hemorrhoid Cream and Injector Customers
10 Concluding Insights
11 Appendix
11.1 Reasons for Doing This Study
11.2 Research Methodology
11.3 Research Process
11.4 Authors List of This Report
11.5 Data Source
11.5.1 Secondary Sources
11.5.2 Primary Sources
11.6 Disclaimer
How Do Licenses Work?
Head shot

Questions or Comments?

Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.